FDA warns online hormone sellers
From Times wire services
Government health officials on Wednesday began cracking down on Internet sales of custom-mixed hormones for menopausal women, a market born when doctors deemed prescription estrogen therapy too risky for many.
But the Food and Drug Administration says these alternative hormone mixes are no safer and told seven makers to stop selling them.
The FDA said it sent warning letters to the companies saying their claims about the “bio-identical hormone replacement therapy” -- or BHRT -- products are not supported by medical evidence and are considered false and misleading. The agency said it is concerned the claims for safety and effectiveness mislead patients and healthcare professionals.
